Literature DB >> 11460509

Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver disease.

D Medicina1, G Fabbretti, S O Brennan, P M George, B Kudryk, F Callea.   

Abstract

Fibrinogen storage in liver cells can occur under three different morphological inclusions. Type I contain all three fibrinogen chains (A alpha, B beta, and gamma) as well as D and E fragments, whereas type II and III lack B beta as well as D and E fragments. Patients with type I inclusions carry a point mutation (gamma 284 Gly-Arg). The mutation is not present in patients with type II and III inclusions. These results appear to suggest that the three various phenotypic expressions (i.e., morphological variants) reflect different genetical abnormalities of fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11460509     DOI: 10.1111/j.1749-6632.2001.tb03538.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Liver glycogen bodies: ground-glass hepatocytes in transplanted patients.

Authors:  Pablo A Bejarano; Monica T Garcia; Maria M Rodriguez; Phillip Ruiz; Andreas G Tzakis
Journal:  Virchows Arch       Date:  2006-09-22       Impact factor: 4.064

Review 2.  Diagnosis of inherited disorders of liver metabolism.

Authors:  P T Clayton
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

3.  Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy.

Authors:  Z Simsek; O Ekinci; M Cindoruk; T Karakan; B Degertekin; G Akyol; S Unal
Journal:  BMC Gastroenterol       Date:  2005-11-15       Impact factor: 3.067

Review 4.  The Recruitment-Secretory Block ("R-SB") Phenomenon and Endoplasmic Reticulum Storage Diseases.

Authors:  Francesco Callea; Paolo Tomà; Emanuele Bellacchio
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

5.  Fibrinogen storage disease in a Chinese boy with de novo fibrinogen Aguadilla mutation: Incomplete response to carbamazepine and ursodeoxycholic acid.

Authors:  Mei-Hong Zhang; A S Knisely; Neng-Li Wang; Jing-Yu Gong; Jian-She Wang
Journal:  BMC Gastroenterol       Date:  2016-08-12       Impact factor: 3.067

6.  Fibrinogen Gamma Chain Mutations Provoke Fibrinogen and Apolipoprotein B Plasma Deficiency and Liver Storage.

Authors:  Francesco Callea; Isabella Giovannoni; Sinan Sari; Esendagli Guldal; Buket Dalgic; Gulen Akyol; Tsuyoshi Sogo; Abdulrahman Al-Hussaini; Giuseppe Maggiore; Andrea Bartuli; Renata Boldrini; Paola Francalanci; Emanuele Bellacchio
Journal:  Int J Mol Sci       Date:  2017-12-15       Impact factor: 5.923

7.  Hepatic fibrinogen storage disease and hypofibrinogenemia caused by fibrinogen Aguadilla mutation: a case report.

Authors:  Leilei Gu; Bin Wang; Lu Liu; Qiaorong Gan; Xiaolong Liu; Lihong Chen; Li Chen
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

8.  Structural Characteristics in the γ Chain Variants Associated with Fibrinogen Storage Disease Suggest the Underlying Pathogenic Mechanism.

Authors:  Guven Burcu; Emanuele Bellacchio; Elif Sag; Alper Han Cebi; Ismail Saygin; Aysenur Bahadir; Guldal Yilmaz; Marialuisa Corbeddu; Murat Cakir; Francesco Callea
Journal:  Int J Mol Sci       Date:  2020-07-20       Impact factor: 5.923

Review 9.  The Discovery of Endoplasmic Reticulum Storage Disease. The Connection between an H&E Slide and the Brain.

Authors:  Francesco Callea; Valeer Desmet
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.